Endothelial progenitor cells (EPCs) can be isolated from adult peripheral and umbilical cord blood and expanded exponentially ex vivo. In contrast, human umbilical vein endothelial cells (HUVECs) or human aortic endothelial cells (HAECs) derived from vessel walls are widely considered to be differentiated, mature endothelial cells (ECs).
Introduction
Endothelial progenitor cells (EPCs) can be isolated from adult peripheral and umbilical cord blood (UCB) [1] [2] [3] [4] [5] [6] [7] [8] [9] . EPCs are thought to originate from bone marrow and circulate in peripheral blood 1, 2 . Experimental evidence to support the use of EPCs for angiogenic therapies or as biomarkers to assess cardiovascular disease risk and progression is compelling 1, 2, [10] [11] [12] [13] . Currently, there is no uniform definition of an EPC, which makes interpretation of these studies difficult, and EPCs are primarily defined by expression of cell surface antigens 1, 2 . However, a hallmark of stem and progenitor cells is their ability to proliferate and give rise to functional progeny 14 , and progenitor cells are identified by their clonogenic potential 14 . Based on these principles, we recently developed a single cell clonogenic assay to define a novel hierarchy of EPCs based on their proliferative and clonogenic potential 15 .
In contrast to EPCs, HUVECs and HAECs, which are derived from vessel walls, are considered to be differentiated, mature ECs and are utilized as "controls" for EPC studies 4, 5, 16, 17 . However, similar to adult and UCB derived EPCs, HUVECs and HAECs can be passaged for at least 40 population doublings 4, 16, 17 . 
Materials and Methods

Umbilical cord blood samples
Human UCB samples from term newborns were collected as previously described 15 .
The Institutional Review Board at the Indiana University School of Medicine approved all protocols, and informed consent was obtained from all adult donors and parents of newborns.
Buffy coat cell preparation of umbilical cord blood samples
Mononuclear cells (MNCs) were isolated as previously described 15 and washed with EGM-2 medium (Cambrex, Walkersville, MD) supplemented with 10% fetal bovine serum (Hyclone, Logan, UT), 2% penicillin/streptomyocin (Invitrogen, Grand Island, NY) and 0.25 µg/ml of amphotericin B (Invitrogen) (complete EGM-2 medium).
Culture of umbilical cord blood endothelial cells
MNCs were seeded onto tissue culture plates pre-coated with type I rat tail collagen (BD Biosciences, Bedford MA) in complete EGM-2 medium at 37ºC, 5% CO 2 in a humidified incubator, and cultured for EC colony growth as previously described 15 . EC colonies appeared between 5-10 days of culture. The ECs were expanded in complete EGM-2 media as previously described 15 .
Culture of HUVECs and HAECs
Cryopreserved human umbilical vein endothelial cells (HUVECs) and human aortic endothelial cells (HAECs) were obtained from Cambrex at passage three. Cells were 
Generation of GALV-pseudotyped MFG-EGFP and Retroviral transduction of ECs
The MFG-EGFP retrovirus vector expressing the enhanced green fluorescent protein (EGFP) under the control of the Moloney murine leukemia virus long terminal repeat was employed as previously described 18 . Supernatant from MFG-EGFP clone 5 with a titer of 0.5-1 x 10 6 infectious units/ml was used. ECs were transduced with MGF-EGFP supernatant as previously described and analyzed for EGFP expression by FACS 15 .
Single cell assays
ECs transduced with the MFG-EGFP retrovirus were sorted by FACS for EGFP . At day 14, wells were examined for EC growth. We scored as positive those wells in which two or more ECs were identified using a fluorescent microscope.
Cells were counted as previously described 15 . Wells containing greater than 50 cells were subcultured to a 24 well tissue culture plate. On day 7, wells were examined for secondary colony growth or cell confluence.
Telomerase Activity Assay
Telomerase activity was measured by the telomeric amplification protocol (TRAP) as previously described 19 using the TRAP-eze telomerase detection kit (Chemicon, Temecula, CA). Cell lysate from 10 3 cells were used for each assay. The PCR product p. 7
and a 6-base pair incremental ladder were electrophoresed on a 12.5% non-denaturing polyacrylamide gel and visualized by SYBR gold staining (Molecular Probes).
Results and Discussion
To As shown previously, the percentage of single cord blood ECs undergoing at least one cell division was 55% (Figure 2A) . Similarly, 52% of single HUVECs and 53% of single HAECs divided after 14 days (Figure 2A) . 47% of the single cord blood ECs, which divided formed well-circumscribed colonies containing greater than 2000 cells ( Figure   2B ). Strikingly, 28% of single HUVECs and 27% of single HAECs, which divided, formed colonies containing greater than 2000 cells. In addition, single cord blood ECs, HUVECs and HAECs formed smaller colonies which contained between 51 and 500 cells or less than 50 cells ( Figure 2B ). We previously described these colonies as low proliferative potential -endothelial colony forming cells (LPP-ECFC) and endothelial cell clusters (Endo-clusters), respectively 15 . Photomicrographs of the clusters and colonies derived from single cord blood ECs, HUVECs, and HAECs are shown in Figure 2C .
In hematopoiesis, the most proliferative progenitor that can be cultured in the absence of a stromal cell monolayer is termed the high proliferative potential-colony forming cell (HPP-CFC) 14, 20 . We recently showed that a similar cell exist in endopoiesis, which we termed the high proliferative potential-endothelial colony forming cell (HPP-ECFC) 15 .
Single HPP-ECFCs yield macroscopic colonies that form secondary and tertiary colonies upon replating Figure 2E . Consistent with their high proliferative potential, clonal progeny derived from HPP-ECFC isolated from cord blood ECs, HUVECs or HAECs contained higher telomerase activity compared to the progeny derived from LPP-ECFCs ( Figure 2F ).
However, FGF receptor expression was not different in the HPP-ECFC colonies compared to the LPP-ECFC colonies (data not shown).
HUVECs and HAECs derived from vessel walls are considered to be differentiated, mature ECs 4, 16, 17 . However, we show that a complete hierarchy of EPCs can be identified in HUVEC and HAEC monolayers and discriminated by their clonogenic potential. This data explains why HUVECs and HAECs can be passaged for at least 40 population doublings given that HPP-ECFCs and LPP-ECFCs exist in HUVEC and HAEC populations. We are now testing whether EPCs also exist in other human adult vessels, which would provide a new conceptual framework for determining both the origin and function of EPCs in maintaining vessel integrity. 
